Drabik, A., Sturm, A., Blömacher, M., & Helwig, U. (2016). Early Monitoring of Response (MORE) to Golimumab Therapy Based on Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study. JMIR Res Protoc.
Citación estilo ChicagoDrabik, Attyla, Andreas Sturm, Margit Blömacher, y Ulf Helwig. "Early Monitoring of Response (MORE) to Golimumab Therapy Based On Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study." JMIR Res Protoc 2016.
Cita MLADrabik, Attyla, Andreas Sturm, Margit Blömacher, y Ulf Helwig. "Early Monitoring of Response (MORE) to Golimumab Therapy Based On Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study." JMIR Res Protoc 2016.